Auburn University MRI Center and Edward Via College of Medicine
Auburn, Alabama, 36832, United States
NCT Number: NCT06841627
Chronic headaches are associated with changes in brain structure and function that may be associated with increased suffering and disability. Understanding how Osteopathic Manipulative Therapy (OMT) affects these changes would reveal new insight into how the brain processes pain and returns to normal function. Also, demonstrating these changes would provide evidence regarding how OMT causes a reduction in pain and disability, supporting the recommendation for OMT as a primary treatment option for headaches.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Auburn, Alabama, 36832, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Evaluation looking for Somatic Dysfunction (SD) involving the head, neck, upper thoracic spine, rib cage and sacroiliac joint. OMT techniques will include a mix of the following: Osteopathic Cranial Manipulative Medicine, Muscle Energy Technique, Facilitated Positional Release, Indirect Myofascial Release, and Counterstrain.
Time frame: From enrollment to the end of treatment at 5 weeks
Structural MRI will assess physical changes in brain anatomy, including differences in the size, shape, or density of specific brain regions. For example, changes in gray matter volume or white matter integrity may indicate neuroplasticity changes response to an OMT. Functional MRI (fMRI) will measure brain activity by detecting changes in blood flow within the central pain network. When a specific brain region becomes more active, it requires more oxygen, which fMRI can detect. This will help determine whether the intervention alters brain function, such as increased activation in areas involved in movement, memory, or pain processing. Magnetic Resonance Spectroscopy (MRS), unlike standard MRI, which provides images of brain structures, will analyze chemical changes in the brain. It detects levels of important brain metabolites involved in neural signaling neuronal health.
Time frame: From enrollment to the end of treatment at 5 weeks
The HIT-6 (Headache Impact Test-6) measures how headaches affect daily life, including pain severity, frequency, and impact on work and social activities.
Time frame: From enrollment to the end of treatment at 5 weeks
The SF-36 (Short Form-36 Health Survey) is a 36 question survey that assesses overall physical and mental well-being, evaluating factors like physical function, pain, energy levels, and emotional health.
Time frame: From enrollment to the end of treatment at 5 weeks
The DASS-21 (Depression, Anxiety, and Stress Scale-21) is a 21 question survey that examines emotional well-being by measuring levels of depression, anxiety, and stress.
Time frame: From enrollment to the end of treatment at 5 weeks
Headache intensity will be measured by an 11 point numerical rating scale from 0 (no pain) to 10 (worst possible pain).
Edward Via Virginia College of Osteopathic Medicine
Other
Exploring the Mechanism of Osteopathic Manual Therapy (OMT) on Brain Structure and Function in Primary Headache Patients: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05153876
Brain Diseases, Central Nervous System Diseases
Ghent, Belgium
View Trial DetailsNCT01898455
Brain Diseases, Central Nervous System Diseases
Penrith, Cumbria, United Kingdom
View Trial DetailsNCT00205894
Brain Diseases, Central Nervous System Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT06503328
Brain Diseases, Central Nervous System Diseases
Pavia, Italy
View Trial Details